AMGEN INC
AMGNNasdaqGSLatest results at a glance
Insights from the latest company results and reports
Quarterly Earnings Exceed Consensus
Reported EPS of $6.29 per share for the quarter ended 2026-06-30 exceeded the same-quarter consensus estimate of $5.62 per share.
Revenue Growth Accelerates
Revenue for the quarter ended 2026-06-30 was $10.05bn, up 9.53% from $9.18bn in the same quarter of the prior year.
Net Income Rises Sharply
Net income for the quarter ended 2026-06-30 was $2.38bn, up 65.85% from $1.43bn in the quarter ended 2025-06-30.
Gross Margin Expands
Gross margin for the quarter ended 2026-06-30 was 72.04%, wider than the 67.20% recorded for the quarter ended 2025-06-30.
EVENITY Revenue Surges
EVENITY revenue of $550.0m was 5.5% of consolidated revenue for the period ended 2026-06-30, up 39.2% from $395.0m in 2025-06-30.
Enbrel Revenue Declines
Enbrel revenue of $574.0m was 5.7% of consolidated revenue for the period ended 2026-06-30, down 3.9% from $597.0m in 2025-06-30.
Company research evidence
Checked financial measurements with the values, reporting periods and measurement basis shown together. This evidence is available independently of the AI report.
Loading evidence…
Deep Dive Research
Source-linked company research for AMGN
Revenue segmentation
Loading segment disclosures…